EU Politicians: 'Bring Pharma Manufacturing Back To Europe'
EFPIA Expresses Concern About Some Proposals In Report
Executive Summary
The pharmaceutical industry has given a muted welcome to proposals for building up the EU's resilience to medicine shortages, saying many of the ideas will not tackle the root causes of supply problems and could even serve to undermine innovation.
You may also be interested in...
Reality Check On UK Production Capacity For COVID-19 Treatments
In the first of a two-part series of articles on the UK COVID-19 Therapeutics Task Force, the Pink Sheet reports on how task force members are examining the role of therapeutics in tackling the pandemic and why the UK’s manufacturing capability needs to be strengthened so it can meet future demand. The second article will cover the work of the task force and how it is structured to identify and advance promising coronavirus treatments.
Manufacturing Incentives, Flexible Regulations Seen As Remedy For EU Drug Shortages
A committee of influential politicians in Europe are calling for measures that will see the EU become more self-sufficient in the production of medicines, thereby reducing medicine shortages and dependence on imports from third countries.
EU To Kick Off ‘Joint Action’ On Tackling Drug Shortages
The joint action on ensuring security of medicines supply will be supported by the EU regulators’ shortages task force, which is to track efforts to coordinate member state activities on the supply and availability of medicines.